hiv-1-infected patient	suffer from	milder form of hiv-1-associated neurocognitive disorder


individual	be with	serious mental illness such schizophrenia
quality	long-term health of	life
nih-funded randomize clinical trial	examine	effectiveness of group lifestyle intervention enhance with mobile health technology

reduction	be	key pathological feature associate with hiv-associated neurocognitive disorder

hiv protein	be still produce	inhibit by cart
complement	be require for	loss

c1qa knockout mouse	however have	same level of tat-induced synapse loss as wild-type mouse

